Our customers are academic labs, institute, anticancer centers, biotechnology and mid-sized to big pharmaceutical companies which develop drugs against cancer and test the in vivo toxicity of their candidate compounds.
Why our clients use our assays:
- Early stage evaluation to eliminate low value molecules before classical preclinical studies
- Very affordable cost than comparable techniques for a first in vivo proof of concept
- More large possibility to in vivo screening with a same budget
- File a patent, we offer the initial in vivo proof of concept
- Generation of the first in vivo data for a publication
- In vivo assays yet without animal experimentation
After using INOVOTION's assays, most of our customers make a second study or more because these assays have a real added value in comparison to classical preclinical model.
If you have questions or comments about our services, technologies and offers, please send an email to customers@inovotion.com
